GeneWeave Biosciences attracts USD12m in venture capital round
GeneWeave Biosciences, developer of a platform for the rapid detection of infectious disease, has raised USD12 million in a series A round of venture capital led by Decheng Capital. Existing investors Claremont Creek Ventures and X/Seed Capital also participated in the round. The company also announced that Min Cui (pictured),